June 3, 2016: CTSA Trial Innovation Network
CTSA Trial Innovation Network: Early Vision & Goals
Monica Shah, MD, National Center for Advancing Translational Sciences
CTSA; NIH; RIC; TIC; Translational research; Clinical trials; Trial Innovation Network
- NIH’s National Center for Advancing Translational Sciences (NCATS) is starting a Trial Innovation Network to leverage its CTSA program to transform clinical trials.
- The network is designed to accelerate the planning and implementation of high-quality multi-center trials. The network will focus on the elements of operational innovation and excellence to achieve this goal. It will include Trial Innovation Centers (TICs), Recruitment Innovation Centers (RICs), CTSA hubs, and other partners. It is envisioned that the network will serve as a national laboratory to study, understand, and improve clinical trials. The network will start by conducting smaller demonstration studies and will eventually conduct large-scale clinical trials.
- The network is still being developed, and NCATS is interested in input, engagement, and partnerships.
Partnerships will be important to the success of the Trial Innovation Network and may help bring cutting-edge innovations from outside the CTSA program; potential partners mentioned included PCORnet, NIH Collaboratory, VA, and private/industry partners
Community and patient engagement, which are important elements of the CTSA program, will also be important elements of the Trial Innovation Network
The network will need to market itself to investigators to get them to use it, as it will be different from their comfortable way of doing trials
The network and clinical research in general should aim to recognize and reward efforts in all aspects of clinical trials and not just protocol development
#CTSA; #clinicaltrials; #PatientEngagement
@PCTGrandRounds, @Collaboratory1, @ncats_nih_gov